Areximbank offers 50% annual maintenance discount for premium class chip-embedded mastercard gold and visa gold payment cards

YEREVAN, June 27. /ARKA/. As part of Suitcase Mood vocational campaign running from June 27 to September 30 all customers of Areximbank –Gazprombank Group, who will purchase insurance policies for traveling  abroad will be offered premium class chip-embedded MasterCard Gold and VISA Gold payment cards with a 50% discount for annual maintenance.

The type of currency on the card – USD, Euro, RUR, AMD – is to be specified by the customer, the bank’s press service reported.

When using MasterCard Maestro, MasterCard Standard, MasterCard Gold cards to pay for goods at different trade outlets in Armenia, customers using POS-terminals and e-commerce service are provided with 1% cash-back.

Areximbank – Gazprombank Group founded in 1998 is now entirely owned by Russian Gazprombank.-0-

spot_img

POPULAR

US dollar, euro, and ruble drop against Armenian dram

YEREVAN, August 18. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market as of August 18, 2026, fell by 0.25 points to 365.25 drams compared to August 17.

Record growth of Armenia’s reserves to $6.9 billion in June provided a buffer amid heightened geopolitical risks – S&P

Armenia's international reserves increased by approximately 40% year-on-year to a record $6.9 billion in June 2026, helping to strengthen the country's external reserves despite heightened geopolitical risks, according to a report by international rating agency S&P Global Ratings.

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

S&P: Armenia’s banking sector is well capitalized and highly profitable

Armenia's banking sector remains well capitalized and highly profitable, supported by high net interest income and robust economic growth, according to a report from international rating agency S&P Global Ratings.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img